Gunderson Dettmer has advised RIGImmune in its acquisition by Leyden Labs. Leyden Laboratories B.V. has completed its acquisition of RIGImmune, a biopharmaceutical company specializing in immune…
Leyden Labs Acquires RIGImmune to Expand Airway-Targeted Medicines Portfolio
